Drugs and porphyric crisis Fármacos y crisis porfírica.
Author
dc.contributor.author
Hernández,
Author
dc.contributor.author
Parraguez,
Author
dc.contributor.author
Wolff Fernández, Carlos
Author
dc.contributor.author
Armas-Merino, Rodolfo
Admission date
dc.date.accessioned
2019-01-29T14:13:51Z
Available date
dc.date.available
2019-01-29T14:13:51Z
Publication date
dc.date.issued
1992
Cita de ítem
dc.identifier.citation
Revista medica de Chile, Volumen 120, Issue 7, 2018, Pages 803-806
Identifier
dc.identifier.issn
00349887
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/160230
Abstract
dc.description.abstract
Life threatening crisis may accompany some varieties of porphyria like the acute intermittent form, coproporphyria, porphyria variegata and that associated to deficiency of porphobilinogen synthetase. Drugs are commonly involved as precipitating factors. A classification of drugs according to their proven or probable triggering effect is offered in this paper. Insufficient information precludes the classification of some drugs.